Canopy(1) | $22,000,000 | (Jan 13, 2026)
Onsetto | $2,200,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
Certified by Founder
Lodge
Qritive
start up
Singapore
- Singapore, Singapore
- 11/01/2023
- Unknown
- $7,500,000
Qritive makes cancer diagnosis fast, cheap, and accurate.
During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs.
- Industry Software Development
- Website https://qritive.com/
- LinkedIn https://www.linkedin.com/company/qritive/
Related People
Aneesh Sathe, Ph.D.Co Founder
United States -
ND
At Qritive, we make cancer diagnosis fast, accurate, and affordable.
Qritive provides an AI-powered solution to help doctors analyse microscopy images for histopathology. As a result, hospitals and labs will be more efficient in making cancer diagnoses, allowing them to save costs.
Cytotheryx, Inc. | $60,000,000 | (Jan 13, 2026)
MEDIPOST, Inc. | $140,000,000 | (Jan 13, 2026)
TRYBE | $30,000,000 | (Jan 13, 2026)
Kinaset Therapeutics | $103,000,000 | (Jan 13, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
VelaFi | $20,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
Vibrant Therapeutics | $61,000,000 | (Jan 13, 2026)
Avenue Biosciences | $7,500,000 | (Jan 13, 2026)
Unusual | $3,600,000 | (Jan 13, 2026)